Found 62 articles for: "COVID-19"
Clinical Study to Evaluate the Efficacy and Tolerability of Cosmeceuticals Targeting the Dermal-Epidermal Junction
December 2021 | Volume 20 | Issue 12 | Original Article | 1314 | Copyright © December 2021
Objective: The dermal-epidermal junction (DEJ), composed of rare proteins, plays a significant role in facial skin aging. A newly enhanced multi-ingredient anti-aging facial moisturiz...
December 2021 | Volume 20 | Issue 12 | Supplement Individual Articles | ss4 | Copyright © December 2021
Preventive measures, earlier diagnosis, and markedly improved anticancer treatments have resulted in increasingly more patients living with or surviving cancer. Frequently cancer treatment-related cut...
December 2021 | Volume 20 | Issue 12 | Original Article | 1295 | Copyright © December 2021
Hidradenitis suppurativa (HS) is a chronic debilitating skin disease characterized by painful dermal abscesses, subcutaneous inflammatory nodules, draining sinuses and hypertrophic scars. Prompt recog...
Delayed Metastatic Polypoid Nodular Melanoma Diagnosis During COVID-19 Pandemic, Successful Treatment With Surgery and Nivolumab
December 2021 | Volume 20 | Issue 12 | Case Reports | 1343 | Copyright © December 2021
Patients with polypoid (pedunculated) melanoma have the poorest 5-year survival rate compared with all other variants of nodular melanoma, presenting with increased thickness, incidence of metastasis,...
Optimizing Outcomes With the 1550/1927 nm Dual Wavelength Non-Ablative Fractional Laser: Experienced User Recommendations
November 2021 | Volume 20 | Issue 11 | Original Article | 1150 | Copyright © November 2021
Background: Fractional laser treatment was introduced in 2004 as a non-invasive technique to treat sun-damaged and aging skin. Since then, numerous ablative and non-ablative photother...
November 2021 | Volume 20 | Issue 11 | Supplement Individual Articles | ss3s | Copyright © November 2021
Background: Nonenergy and injectable treatments are frequently used for facial rejuvenation. Many publications have addressed methods to reduce adverse events related to the procedure...
October 2021 | Volume 20 | Issue 10 | Original Article | 1063 | Copyright © October 2021
While biological treatments for chronic plaque psoriasis should be administered continuously to maximize and maintain efficacy, interruptions in therapy may be necessary for a number of reasons. We re...
October 2021 | Volume 20 | Issue 10 | Original Article | 1076 | Copyright © October 2021
Background: Onychomycosis affects around 14% of individuals in North America and Europe and is undertreated. Treatment is challenging as toenail growth can take 12–18 months, th...
Racial/Ethnic Variations in Skin Barrier: Implications for Skin Care Recommendations in Skin of Color
September 2021 | Volume 20 | Issue 9 | Original Article | 932 | Copyright © September 2021
Background: Genetic and environmental factors influence stratum corneum (SC) barrier properties and function. Researchers increasingly focus on biophysical studies that may help clini...
Health Policy Education in U.S. Dermatology Residency Programs: A Nationwide Survey of Program Leadership
September 2021 | Volume 20 | Issue 9 | Editorials | 1009 | Copyright © September 2021
A Randomized, Double-Blind, Active- and Placebo-Controlled Trial Evaluating a Novel Topical Treatment for Keloid Scars
September 2021 | Volume 20 | Issue 9 | Original Article | 964 | Copyright © September 2021
Keloid and hypertrophic scars are fibroproliferative disorders resulting from abnormal wound healing in genetically susceptible individuals. Current therapies are often ineffective. Kynurenine shows p...
September 2021 | Volume 20 | Issue 9 | Editorials | 1013 | Copyright © September 2021
AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study
September 2021 | Volume 20 | Issue 9 | Original Article | 980 | Copyright © September 2021
Objective: To evaluate the efficacy and safety of AbobotulinumtoxinA (ABO) dose escalation in the correction of moderate-to-severe glabellar lines.
COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients
August 2021 | Volume 20 | Issue 8 | Editorials | 914 | Copyright © August 2021
Early in the COVID-19 pandemic, anti-malarial agent hydroxychloroquine (HCQ) was touted as a potentially effective COVID-19 treatment due to its purported antiinflammatory and antiviral effects....
August 2021 | Volume 20 | Issue 8 | Case Reports | 898 | Copyright © August 2021
Vaccination is an important intervention in preventing the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Messenger RNA (mRNA) vaccines from Pfizer™ and Moderna™ a...
August 2021 | Volume 20 | Issue 8 | Original Article | 868 | Copyright © August 2021
The Symposium on Hidradenitis Suppurativa Advances (SHSA) is a joint meeting of the United States Hidradenitis Suppurativa Foundation (HSF) and the Canadian Hidradenitis Suppurativa Foundation (CHSF)....
Combining Panitumumab With Anti-PD-1 Antibody in Cutaneous Squamous Cell Carcinoma of the Head and Neck After Inadequate Response to Anti-PD-1 Antibody Alone
August 2021 | Volume 20 | Issue 8 | Case Reports | 901 | Copyright © August 2021
Anti-epidermal growth factor receptor (EGFR) antibodies and anti-programmed cell death 1 protein (PD-1) antibodies have been used separately to treat metastatic cutaneous squamous cell carcinoma (cSCC...
July 2021 | Volume 20 | Issue 7 | Editorials | 806 | Copyright © July 2021
Identifying Areas for Improvement in Remote Skin Cancer Management: Surveillance, Diagnostics, and Skin of Color
July 2021 | Volume 20 | Issue 7 | Features | 792 | Copyright © July 2021
July 2021 | Volume 20 | Issue 7 | Editorials | 799 | Copyright © July 2021